Enterocin Hybrid 1, identified by the CAS number 2764845-25-0, is a synthetic compound that belongs to a class of substances known for their antimicrobial properties. This compound is characterized by its unique molecular structure, which typically includes a combination of peptide sequences that enhance its biological activity. Enterocin Hybrid 1 is primarily studied for its potential applications in food preservation and as a therapeutic agent against various pathogens, particularly in the context of antibiotic resistance. Its mechanism of action often involves disrupting bacterial cell membranes or inhibiting essential cellular processes, making it effective against a range of Gram-positive and Gram-negative bacteria. Additionally, the compound may exhibit stability under various environmental conditions, which is crucial for its practical applications. Research into Enterocin Hybrid 1 continues to explore its efficacy, safety, and potential uses in both clinical and industrial settings, highlighting its significance in the ongoing search for new antimicrobial agents.

Enterocin Hybrid 1

2764845-25-0: Enterocin Hybrid 1, identified by the CAS number 2764845-25-0, is a synthetic compound that belongs to a class of substances known for their antimicrobial properties. This compound is characterized by its unique molecular structure, which typically includes a combination of peptide sequences that enhance its biological activity. Enterocin Hybrid 1 is primarily studied for its potential applications in food preservation and as a therapeutic agent against various pathogens, particularly in the context of antibiotic resistance. Its mechanism of action often involves disrupting bacterial cell membranes or inhibiting essential cellular processes, making it effective against a range of Gram-positive and Gram-negative bacteria. Additionally, the compound may exhibit stability under various environmental conditions, which is crucial for its practical applications. Research into Enterocin Hybrid 1 continues to explore its efficacy, safety, and potential uses in both clinical and industrial settings, highlighting its significance in the ongoing search for new antimicrobial agents.

<p>Enterocin Hybrid 1, an antibacterial agent, effectively inhibits Vancomycin-resistant Enterococcus faecium and Staphylococcus haemolyticus [1].</p>

CAS 2764845-25-0

Enterocin Hybrid 1

Enterocin Hybrid 1

Ref: TM-T80193